XJPX
2668
Market cap54mUSD
Oct 09, Last price
1,278.00JPY
1D
0.24%
1Q
1.75%
Jan 2017
20.11%
IPO
169.05%
Name
Tabio Corp
Chart & performance
P/E
15.24
P/S
0.52
EPS
83.84
Div yield, %
2.35%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
4.21%
Revenues
16.81b
-0.24%
Net income
570m
+9.55%
CFO
917m
-3.56%
Dividend
Feb 25, 202730 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tabio Corporation plans, manufactures, wholesales, and retails socks. The company offers five finger, plain, ankle, crew, high, over knee high, and parts socks; foot covers and cover socks; tights; short, wedding, and all-through stockings; and sports socks comprising running, golf, soccer and futsal, and yoga socks, as well as leg warmers. It also provides health/beauty socks, including inner, pressure, and cold socks, as well as socks for swelling, foot fatigue, foot odor, shoe slip, and sleep measures; leggings and spats; and fresher, ceremonial occasion, suit casual, and long shoe socks. The company offers its products through a chain of franchised and directly managed stores. Tabio Corporation was formerly known as DAN Co., Ltd. and changed its name to Tabio Corporation in September 2006. The company was founded in 1968 and is headquartered in Osaka, Japan.
Key people
Hiroaki Imagawa
Director · since 2024
Teruo Masago
Director · since 2018
Katsuhiro Ochi
President, Representative Director · since 2008
Yasuhiko Ochi
Director · since 2014
Senior Managing Director, Manager of Tokyo Office · since 2013
Shukuzoku Seki
Director of Finance, Director · since 2022
Independent Director · since 2021
Kenichiro Otake
Independent Director · since 2016
Independent Director · since 2024
Shinji Wada
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑02 | 2025‑02 | 2024‑02 | 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||